TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth

Cell

Volumn 126, Issue 5, 2006, Pages 955-968

  Inoki, Ken ^a,b   Ouyang, Hongjiao ^a   Zhu, Tianqing ^a,b   Lindvall, Charlotta ^d   Wang, Yian ^e   Zhang, Xiaojie ^a   Yang, Qian ^a,b   Bennett, Christina ^b   Harada, Yuko ^f   Stankunas, Kryn ^g   Wang, Cun yu ^a   He, Xi ^f   MacDougald, Ormond A ^b   You, Ming ^e   Williams, Bart O ^d   Guan, Kun Liang ^a,b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

^e USA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE; TUBERIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GROWTH REGULATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 33748153690     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.06.055     Document Type: Article

References (53)

1. Astrinidis A., Senapedis W., Coleman T.R., and Henske E.P. Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B. J. Biol. Chem. 278 (2003) 51372-51379
2. Bafico A., Liu G., Yaniv A., Gazit A., and Aaronson S.A. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol. 3 (2001) 683-686
3. Barker N., and Clevers H. Catenins, Wnt signaling and cancer. Bioessays 22 (2000) 961-965
4. Barry F.A., Graham G.J., Fry M.J., and Gibbins J.M. Regulation of glycogen synthase kinase 3 in human platelets: a possible role in platelet function?. FEBS Lett. 553 (2003) 173-178
5. Bolster D.R., Crozier S.J., Kimball S.R., and Jefferson L.S. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem. 277 (2002) 23977-23980
6. Brugarolas J., and Kaelin Jr. W.G. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell 6 (2004) 7-10
7. Brunner E., Peter O., Schweizer L., and Basler K. pangolin encodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature 385 (1997) 829-833
8. Cook D., Fry M.J., Hughes K., Sumathipala R., Woodgett J.R., and Dale T.C. Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C. EMBO J. 15 (1996) 4526-4536
9. Corradetti M.N., Inoki K., Bardeesy N., DePinho R.A., and Guan K.L. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18 (2004) 1533-1538
10. Corton J.M., Gillespie J.G., Hawley S.A., and Hardie D.G. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. Eur. J. Biochem. 229 (1995) 558-565
11. Dominguez I., and Green J.B. Missing links in GSK3 regulation. Dev. Biol. 235 (2001) 303-313
12. Easwaran V., Lee S.H., Inge L., Guo L., Goldbeck C., Garrett E., Wiesmann M., Garcia P.D., Fuller J.H., Chan V., et al. Beta-catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res. 63 (2003) 3145-3153
13. Fingar D.C., and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
14. Fiol C.J., Mahrenholz A.M., Wang Y., Roeske R.W., and Roach P.J. Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J. Biol. Chem. 262 (1987) 14042-14048
15. Gao X., Zhang Y., Arrazola P., Hino O., Kobayashi T., Yeung R.S., Ru B., and Pan D. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4 (2002) 699-704
16. Hashemolhosseini S., Nagamine Y., Morley S.J., Desrivieres S., Mercep L., and Ferrari S. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol. Chem. 273 (1998) 14424-14429
17. Hay N., and Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 18 (2004) 1926-1945
18. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., and Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406 (2000) 86-90
19. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., Deng L., Clemens T.L., and Williams B.O. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem. 280 (2005) 21162-21168
20. Horman S., Browne G., Krause U., Patel J., Vertommen D., Bertrand L., Lavoinne A., Hue L., Proud C., and Rider M. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12 (2002) 1419-1423
21. Inoki K., Zhu T., and Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115 (2003) 577-590
22. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15-25
23. Kolligs F.T., Kolligs B., Hajra K.M., Hu G., Tani M., Cho K.R., and Fearon E.R. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev. 14 (2000) 1319-1331
24. Kwiatkowski D.J. Tuberous sclerosis: from tubers to mTOR. Ann. Hum. Genet. 67 (2003) 87-96
25. Li Y., Hively W.P., and Varmus H.E. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19 (2000) 1002-1009
26. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., Oppliger W., Jenoe P., and Hall M.N. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10 (2002) 457-468
27. Ma L., Chen Z., Erdjument-Bromage H., Tempst P., and Pandolfi P.P. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121 (2005) 179-193
28. Mak B.C., Takemaru K., Kenerson H.L., Moon R.T., and Yeung R.S. The tuberin-hamartin complex negatively regulates Beta-catenin signaling activity. J. Biol. Chem. 278 (2003) 5947-5951
29. Mak B.C., Kenerson H.L., Aicher L.D., Barnes E.A., and Yeung R.S. Aberrant beta-catenin signaling in tuberous sclerosis. Am. J. Pathol. 167 (2005) 107-116
30. Manning B.D., and Cantley L.C. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28 (2003) 573-576
31. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., and Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411 (2001) 321-325
32. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destree O., and Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86 (1996) 391-399
33. Moon R.T., Kohn A.D., De Ferrari G.V., and Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5 (2004) 691-701
34. Muise-Helmericks R.C., Grimes H.L., Bellacosa A., Malstrom S.E., Tsichlis P.N., and Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273 (1998) 29864-29872
35. Ouyang H., Franceschi R.T., McCauley L.K., Wang D., and Somerman M.J. Parathyroid hormone-related protein down-regulates bone sialoprotein gene expression in cementoblasts: role of the protein kinase A pathway. Endocrinology 141 (2000) 4671-4680
36. Pinson K.I., Brennan J., Monkley S., Avery B.J., and Skarnes W.C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407 (2000) 535-538
37. Polakis P. Wnt signaling and cancer. Genes Dev. 14 (2000) 1837-1851
38. Roux P.P., Ballif B.A., Anjum R., Gygi S.P., and Blenis J. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA 101 (2004) 13489-13494
39. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., and Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272 (1996) 1023-1026
40. Sansom O.J., Reed K.R., van de Wetering M., Muncan V., Winton D.J., Clevers H., and Clarke A.R. Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. J. Biol. Chem. 280 (2005) 28463-28467
41. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
42. Saucedo L.J., Gao X., Chiarelli D.A., Li L., Pan D., and Edgar B.A. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat. Cell Biol. 5 (2003) 566-571
43. Stocker H., Radimerski T., Schindelholz B., Wittwer F., Belawat P., Daram P., Breuer S., Thomas G., and Hafen E. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat. Cell Biol. 5 (2003) 559-565
44. Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., Hess F., Saint-Jeannet J.P., and He X. LDL-receptor-related proteins in Wnt signal transduction. Nature 407 (2000) 530-535
45. Tang E.D., Wang C.Y., Xiong Y., and Guan K.L. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J. Biol. Chem. 278 (2003) 37297-37305
46. Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
47. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111 (2002) 241-250
48. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates III J.R., and Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423 (2003) 448-452
49. Wodarz A., and Nusse R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14 (1998) 59-88
50. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484
51. Zeng L., Fagotto F., Zhang T., Hsu W., Vasicek T.J., Perry III W.L., Lee J.J., Tilghman S.M., Gumbiner B.M., and Costantini F. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90 (1997) 181-192
52. Zhang X., Gaspard J.P., and Chung D.C. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 61 (2001) 6050-6054
53. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 (2001) 1167-1174